Addition of exogenous α-synuclein preformed fibrils to primary neuronal cultures to seed recruitment of endogenous α-synuclein to Lewy body and Lewy neurite–like aggregates (original) (raw)
McNaught, K.S., Shashidharan, P., Perl, D.P., Jenner, P. & Olanow, C.W. Aggresome-related biogenesis of Lewy bodies. Eur. J. Neurosci.16, 2136–2148 (2002). ArticlePubMed Google Scholar
Kopito, R.R. Aggresomes, inclusion bodies and protein aggregation. Trends Cell Biol.10, 524–530 (2000). ArticleCASPubMed Google Scholar
Kramer, M.L. & Schulz-Schaeffer, W.J. Presynaptic α-synuclein aggregates, not Lewy bodies, cause neurodegeneration in dementia with Lewy bodies. J. Neurosci.27, 1405–1410 (2007). ArticleCASPubMedPubMed Central Google Scholar
Luk, K.C. & Lee, V.M. Modeling Lewy pathology propagation in Parkinson's disease. Parkinsonism Relat. Disord.20 (suppl. 1), S85–S87 (2014). ArticlePubMedPubMed Central Google Scholar
Bendor, J.T., Logan, T.P. & Edwards, R.H. The function of α-synuclein. Neuron79, 1044–1066 (2013). ArticleCASPubMed Google Scholar
Kaufman, S.K. & Diamond, M.I. Prion-like propagation of protein aggregation and related therapeutic strategies. Neurotherapeutics10, 371–382 (2013). ArticleCASPubMedPubMed Central Google Scholar
George, S., Rey, N.L., Reichenbach, N., Steiner, J.A. & Brundin, P. α-Synuclein: the long distance runner. Brain Pathol.23, 350–357 (2013). ArticleCASPubMedPubMed Central Google Scholar
Luk, K.C. et al. Exogenous α-synuclein fibrils seed the formation of Lewy body-like intracellular inclusions in cultured cells. Proc. Natl. Acad. Sci. USA106, 20051–20056 (2009). ArticleCASPubMedPubMed Central Google Scholar
Masliah, E. et al. Dopaminergic loss and inclusion body formation in α-synuclein mice: implications for neurodegenerative disorders. Science287, 1265–1269 (2000). ArticleCASPubMed Google Scholar
Giasson, B.I. et al. Neuronal α-synucleinopathy with severe movement disorder in mice expressing A53T human α-synuclein. Neuron34, 521–533 (2002). ArticleCASPubMed Google Scholar
Lee, M.K. et al. Human α-synuclein–harboring familial Parkinson's disease-linked Ala-53→Thr mutation causes neurodegenerative disease with α-synuclein aggregation in transgenic mice. Proc. Natl. Acad. Sci. USA99, 8968–8973 (2002). ArticleCASPubMedPubMed Central Google Scholar
Spillantini, M.G. et al. Filamentous α-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies. Neurosci. Lett.251, 205–208 (1998). ArticleCASPubMed Google Scholar
Baba, M. et al. Aggregation of α-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies. Am. J. Pathol.152, 879–884 (1998). CASPubMedPubMed Central Google Scholar
Fujiwara, H. et al. α-Synuclein is phosphorylated in synucleinopathy lesions. Nat. Cell Biol.4, 160–164 (2002). ArticleCASPubMed Google Scholar
Volpicelli-Daley, L.A. et al. Exogenous α-synuclein fibrils induce Lewy body pathology leading to synaptic dysfunction and neuron death. Neuron72, 57–71 (2011). ArticleCASPubMedPubMed Central Google Scholar
Desplats, P. et al. Inclusion formation and neuronal cell death through neuron-to-neuron transmission of α-synuclein. Proc. Natl. Acad. Sci. USA106, 13010–13015 (2009). ArticleCASPubMedPubMed Central Google Scholar
Frost, B., Jacks, R.L. & Diamond, M.I. Propagation of tau misfolding from the outside to the inside of a cell. J. Biol. Chem.284, 12845–12852 (2009). ArticleCASPubMedPubMed Central Google Scholar
Ren, P.H. et al. Cytoplasmic penetration and persistent infection of mammalian cells by polyglutamine aggregates. Nat. Cell Biol.11, 219–225 (2009). ArticleCASPubMedPubMed Central Google Scholar
Tanik, S.A., Schultheiss, C.E., Volpicelli-Daley, L.A., Brunden, K.R. & Lee, V.M. Lewy body-like α-synuclein aggregates resist degradation and impair macroautophagy. J. Biol. Chem.288, 15194–15210 (2013). ArticleCASPubMedPubMed Central Google Scholar
Dryanovski, D.I. et al. Calcium entry and α-synuclein inclusions elevate dendritic mitochondrial oxidant stress in dopaminergic neurons. J. Neurosci.33, 10154–10164 (2013). ArticleCASPubMedPubMed Central Google Scholar
Buerli, T. et al. Efficient transfection of DNA or shRNA vectors into neurons using magnetofection. Nat. Protoc.2, 3090–3101 (2007). ArticleCASPubMed Google Scholar
Zeitelhofer, M. et al. High-efficiency transfection of mammalian neurons via nucleofection. Nat. Protoc.2, 1692–1704 (2007). ArticleCASPubMed Google Scholar
Jiang, M. & Chen, G. High Ca2+-phosphate transfection efficiency in low-density neuronal cultures. Nat. Protoc.1, 695–700 (2006). ArticleCASPubMed Google Scholar
Campenot, R.B., Lund, K. & Mok, S.A. Production of compartmented cultures of rat sympathetic neurons. Nat. Protoc.4, 1869–1887 (2009). ArticleCASPubMed Google Scholar
Luk, K.C. et al. Pathological α-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice. Science338, 949–953 (2012). ArticleCASPubMedPubMed Central Google Scholar
Beaudoin, G.M. III . et al. Culturing pyramidal neurons from the early postnatal mouse hippocampus and cortex. Nat. Protoc.7, 1741–1754 (2012). ArticleCASPubMed Google Scholar
Seibenhener, M.L. & Wooten, M.W. Isolation and culture of hippocampal neurons from prenatal mice. J. Vis. Exp. 10.3791/3634 (26 July 2012).
Churchyard, A. & Lees, A.J. The relationship between dementia and direct involvement of the hippocampus and amygdala in Parkinson's disease. Neurology49, 1570–1576 (1997). ArticleCASPubMed Google Scholar
Braak, H. et al. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol. Aging24, 197–211 (2003). ArticlePubMed Google Scholar
Banker, G.A. Trophic interactions between astroglial cells and hippocampal neurons in culture. Science209, 809–810 (1980). ArticleCASPubMed Google Scholar
Bousset, L. et al. Structural and functional characterization of two α-synuclein strains. Nat. Commun.4, 2575 (2013). ArticlePubMed Google Scholar
Murphy, D.D., Rueter, S.M., Trojanowski, J.Q. & Lee, V.M. Synucleins are developmentally expressed, and α-synuclein regulates the size of the presynaptic vesicular pool in primary hippocampal neurons. J. Neurosci.20, 3214–3220 (2000). ArticleCASPubMedPubMed Central Google Scholar
Giasson, B.I., Murray, I.V., Trojanowski, J.Q. & Lee, V.M. A hydrophobic stretch of 12 amino acid residues in the middle of α-synuclein is essential for filament assembly. J. Biol. Chem.276, 2380–2386 (2001). ArticleCASPubMed Google Scholar
Murray, I.V. et al. Role of α-synuclein carboxy-terminus on fibril formation in vitro. Biochemistry42, 8530–8540 (2003). ArticleCASPubMed Google Scholar
Fauvet, B. et al. α-Synuclein in central nervous system and from erythrocytes, mammalian cells, and Escherichia coli exists predominantly as disordered monomer. J. Biol. Chem.287, 15345–15364 (2012). ArticleCASPubMedPubMed Central Google Scholar
Conway, K.A., Harper, J.D. & Lansbury, P.T. Jr. Fibrils formed in vitro from α-synuclein and two mutant forms linked to Parkinson's disease are typical amyloid. Biochemistry39, 2552–2563 (2000). ArticleCASPubMed Google Scholar
Kloepper, K.D., Woods, W.S., Winter, K.A., George, J.M. & Rienstra, C.M. Preparation of α-synuclein fibrils for solid-state NMR: expression, purification, and incubation of wild-type and mutant forms. Protein Expr. Purif.48, 112–117 (2006). ArticleCASPubMed Google Scholar
Bellon, A. et al. Decontamination of prions in a plasma product manufacturing environment. Transfusion54, 1028–1036 (2013). ArticlePubMed Google Scholar
Murphy, R.G. et al. Alkaline hydrolysis of mouse-adapted scrapie for inactivation and disposal of prion-positive material. J. Anim. Sci.87, 1787–1793 (2009). ArticleCASPubMed Google Scholar
Luk, K.C. et al. Intracerebral inoculation of pathological α-synuclein initiates a rapidly progressive neurodegenerative α-synucleinopathy in mice. J. Exp. Med.209, 975–986 (2012). ArticleCASPubMedPubMed Central Google Scholar